Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

SOUTH DAKOTA DEPARTMENT OF HEALTH

SOUTH DAKOTA DEPARTMENT OF HEALTH is a federal contractor, registered under UEI J84PKUEWQ6Y5 and CAGE code 1QGQ8. It has been awarded $1,344,618,900 across 773 federal contracts. Primary work spans Unknown NAICS and Other NAICS codes (7 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Agriculture, and Department Of The Treasury (treas).

Contact Information

Registration and classification details

Registration

UEI Code

J84PKUEWQ6Y5

CAGE Code

1QGQ8

Entity Structure

U.S. Government Entity

Established

N/A

Business Classifications

2F

NAICS Codes

923120Administration of Public Health Programs(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The South Dakota Department of Health delivers critical public health infrastructure services, specializing in laboratory testing, health data systems, and program administration. Its core capabilities include managing high-volume clinical and public health laboratories, implementing secure data pro...

The South Dakota Department of Health delivers critical public health infrastructure services, specializing in laboratory testing, health data systems, and program administration. Its core capabilities include managing high-volume clinical and public health laboratories, implementing secure data processing platforms for vital statistics, and supporting federal health program compliance. The agency operates specialized systems for enumeration at birth, electronic death records, and maternal and child health reporting, ensuring real-time data integrity across state and federal networks. Technical expertise spans secure web hosting, HIPAA-compliant data exchange, laboratory information management systems, and integrated health informatics platforms. A key differentiator is its dual role as both a state health authority and a federal contractor, enabling seamless alignment between public health policy and operational execution. The agency maintains a consistent partnership with the Department of Health and Human Services, primarily supporting national health surveillance initiatives through laboratory services, vital records processing, and quality assurance programs such as MQSA. It also delivers targeted data infrastructure solutions for the Social Security Administration, including birth and death record integration systems that feed into national identity and benefits verification frameworks. These relationships reflect a trusted, long-standing role in federal-state health data interoperability. Its primary focus lies in testing laboratories and computing infrastructure for public health, with deep specialization in health data processing, vital statistics systems, and clinical lab compliance. The agency positions itself as a mission-critical operator in the public health data ecosystem, bridging clinical diagnostics with national surveillance needs. As a state government entity based in Pierre, South Dakota, it operates under a 2A structure as a public agency, not a commercial contractor. While it holds no formal business certifications, its authority derives from state statute and federal delegation, granting it unique access to sensitive health data streams and regulatory oversight roles. Its geographic presence is anchored in South Dakota but extends nationally through federal contracts supporting nationwide health reporting systems.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$949.3M70.6%
Department Of Agriculture$311.4M23.2%
Department Of The Treasury (treas)$75.4M5.6%
Other agencies (13 agencies, <0.5% each)$8.5M0.6%
Awards by NAICS
Export
- Unknown NAICS$1.3B99.4%
Others - Other NAICS codes (7 codes, <0.5% each)$8.1M0.6%
Awards by Agency Over Time
Awards by Place of Performance

Compete with SOUTH DAKOTA DEPARTMENT OF HEALTH

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for SOUTH DAKOTA DEPARTMENT OF HEALTH

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS

Open opportunities in SOUTH DAKOTA DEPARTMENT OF HEALTH's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The National Institutes of Health (NIH) funding opportunity PA-27-102 supports U.S. small business concerns (SBCs) in performing research and development to create commercial products that enhance health, lengthen life, and reduce illness and disability. A mandatory requirement for this Small Business Technology Transfer (STTR) program is a formal collaboration with a non-profit research institution. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit entities located in the U.S. with no more than 500 employees, which must be more than 50 percent owned and controlled by U.S. citizens or permanent resident aliens. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated based on scientific and technical merit through a peer review system, resulting in an overall impact score. Key evaluation criteria include commercial potential, the quality of the commercialization plan, and, for clinical trials, the scientific rationale and regulatory plan. While clinical trials are generally permitted, they are not accepted by specific components such as NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. Recipients must adhere to strict administrative requirements, including maintaining active SAM and UEI registrations, implementing cybersecurity incident reporting procedures with a 48-hour notification window, and registering applicable clinical trials on ClinicalTrials.gov. Submissions must be made via Grants.gov and tracked through eRA Commons, with a response deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products that support the missions of these agencies. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility and Phase II advancing the research toward commercialization. Eligible applicants include for-profit U.S. businesses with fewer than 500 employees. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications. Funding levels vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Awards are based on scientific and technical merit, fund availability, and relevance to program goals, with a heavy emphasis on significance, environment, and commercial potential. While clinical trials are generally permitted, certain institutes, including the FDA components and NCATS, do not accept them under this specific notice. Applicants must maintain active SAM registration and a Unique Entity Identifier. Special requirements include a 48-hour cybersecurity incident reporting window and mandatory registration of applicable clinical trials on ClinicalTrials.gov. Applications must be submitted electronically via ASSIST, Grants.gov Workspace, or an institutional system-to-system solution by the deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, under solicitation PAR-27-098, provides later-stage research and development and technical assistance to small business concerns that have previously received an NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough award. The program is designed to bridge the gap between late-stage development and full commercialization by supporting activities such as clinical trials, IND or IDE-enabling studies, manufacturing scale-up, regulatory strategy, and intellectual property planning. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in the oversight and management of the project. The maximum project period is three years, and funding levels vary by NIH institute, ranging from 500,000 to 2,000,000 dollars. Eligible applicants must maintain active registrations in the System for Award Management and the SBA Company Registry. Applications are evaluated based on scientific and technical merit through a peer review system, with a focus on the project's likelihood to exert a powerful influence on the relevant market. Certain NIH components, including the NHLBI, NIAID, and NCATS, among others, do not accept clinical trials under this specific funding opportunity. Prohibited costs include patent or FDA filing fees and separate Technical and Business Assistance funding. All applications must be submitted electronically by the specified deadlines, with the program expiring on April 6, 2029.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details